Canadá - inglés - Health Canada

dominion pharmacal - doxazosin (doxazosin mesylate) - tablet - 1mg - doxazosin (doxazosin mesylate) 1mg - alpha-adrenergic blocking agents

Canadá - inglés - Health Canada

dominion pharmacal - doxazosin (doxazosin mesylate) - tablet - 2mg - doxazosin (doxazosin mesylate) 2mg - alpha-adrenergic blocking agents

Canadá - inglés - Health Canada

dominion pharmacal - doxazosin (doxazosin mesylate) - tablet - 4mg - doxazosin (doxazosin mesylate) 4mg - alpha-adrenergic blocking agents

Canadá - inglés - Health Canada

teva canada limited - tamsulosin hydrochloride - capsule (sustained-release) - 0.4mg - tamsulosin hydrochloride 0.4mg - selective alfa-1-adrenergic blocking agents

Canadá - inglés - Health Canada

ranbaxy pharmaceuticals canada inc. - tamsulosin hydrochloride - capsule (sustained-release) - 0.4mg - tamsulosin hydrochloride 0.4mg - selective alfa-1-adrenergic blocking agents

Canadá - inglés - Health Canada

mylan pharmaceuticals ulc - tamsulosin hydrochloride - capsule (extended release) - 0.4mg - tamsulosin hydrochloride 0.4mg - selective alfa-1-adrenergic blocking agents

Canadá - inglés - Health Canada

sandoz canada incorporated - tamsulosin hydrochloride - capsule (sustained-release) - 0.4mg - tamsulosin hydrochloride 0.4mg - selective alfa-1-adrenergic blocking agents

Canadá - inglés - Health Canada

triton pharma inc - tamsulosin hydrochloride - capsule (sustained-release) - 0.4mg - tamsulosin hydrochloride 0.4mg - selective alfa-1-adrenergic blocking agents

Canadá - inglés - Health Canada

jamp pharma corporation - tamsulosin hydrochloride - capsule (sustained-release) - 0.4mg - tamsulosin hydrochloride 0.4mg - selective alfa-1-adrenergic blocking agents

Estados Unidos - inglés - NLM (National Library of Medicine)

preferred pharmaceuticals, inc - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin 1 mg - terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules. the long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin capsules are also indicated for the treatment of hypertension. terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.